Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Biotron Limited ( (AU:BIT) ) has shared an update.
Biotron Limited has announced a renounceable pro rata offer to its eligible shareholders, aiming to raise approximately $2.7 million through the issuance of new shares. The offer, partially underwritten by Mahe Capital Pty Limited, is intended to strengthen the company’s financial position and support its ongoing operations in the biotechnology sector.
More about Biotron Limited
Biotron Limited operates in the biotechnology industry, focusing on the development of antiviral therapies. The company’s primary products are aimed at addressing viral infections, with a market focus on innovative medical solutions.
YTD Price Performance: 390.0%
Average Trading Volume: 23,250
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $2.8M
See more data about BIT stock on TipRanks’ Stock Analysis page.